Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence

Inclusion Criteria: * female, cisgender * \>= 18 years * The patient agrees to comply with the contraception requirements detailed in the protocol. * SBP \> 10 cmHg * Heart rate \>= 55 bpm * Received for consultation regarding sexual violence at the Medical-Legal Unit (UMJ) for sexual assault and/or rape within 72 hours of the incident occurring. * Affiliated with a social security system * Patient who understands and reads french * Free, informed, and written consent signed by the participant Exclusion Criteria: * Protected adult (guardianship, curatorship, judicial protection) * Repeated or chronic sexual violence * Impaired consciousness or alertness, amnesia regarding events * Known hypersensitivity to propranolol or treated asthma, even if only occasional * Known interactions with Propranolol (combinations not recommended and combinations to be used with caution) indicated in the summary of product characteristics * Patients who have suffered head trauma within the last year or who have clinical symptoms and neurological sequelae * Patient with myasthenia gravis, with a personal history of psoriasis * Patient wearing contact lenses * Patient with severe liver disease and/or significant renal impairment * Current use of a beta-blocker, regardless of dosage form. * Current use of a drug that has a contraindicated or inadvisable drug interaction with propranolol: bepridil, diltiazem, verapamil, fingolimod. * Addiction: presence of a current disorder related to the use of psychoactive substances. * Current treatment with benzodiazepines * Individuals currently receiving psychotropic treatment such as antipsychotics or antidepressants. * People with known current or past serious psychiatric disorders. * High suicide risk, i.e., participants who responded positively to items 4 or 5 of the C-SSRS suicidal ideation scale or any positive assessment of suicidal behavior in the 6 months prior to selection. * Patients who have previously been diagnosed with PTSD. * Pregnant or breastfeeding women.